{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:13:43Z","timestamp":1784909623555,"version":"3.55.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.juro.2007.05.041","type":"journal-article","created":{"date-parts":[[2007,7,17]],"date-time":"2007-07-17T07:18:31Z","timestamp":1184656711000},"page":"896-901","source":"Crossref","is-referenced-by-count":78,"title":["Examination of the Relationship Between Symptoms of Prostatitis and Histological Inflammation: Baseline Data From the REDUCE Chemoprevention Trial"],"prefix":"10.1097","volume":"178","author":[{"given":"J. Curtis","family":"Nickel","sequence":"first","affiliation":[{"name":"Department of Urology, Queen\u2019s University, Kingston General Hospital, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus G.","family":"Roehrborn","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"O\u2019Leary","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, Harvard Medical School, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Bostwick","sequence":"additional","affiliation":[{"name":"Bostwick Laboratories, Glen Allen, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Somerville","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Rittmaster","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2007.05.041_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.282.3.236","article-title":"NIH consensus definition and classification of prostatitis","volume":"282","author":"Krieger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2007.05.041_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-5347(05)68562-X","article-title":"The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure","volume":"162","author":"Litwin","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.05.041_bib3","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/S0022-5347(05)68090-1","article-title":"Prostate histopathology and the chronic prostatitis\/chronic pelvic pain syndrome: a prospective biopsy study","volume":"162","author":"True","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.05.041_bib4","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/01.ju.0000139320.78673.2a","article-title":"Chemoprevention of prostate cancer in men at high risk: rationale and design of the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial","volume":"172","author":"Andriole","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.05.041_bib5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0022-5347(05)66541-X","article-title":"Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index","volume":"165","author":"Nickel","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.05.041_bib6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1046\/j.1464-410x.2001.02193.x","article-title":"Consensus development of a histopathological classification system for chronic prostatic inflammation","volume":"87","author":"Nickel","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2007.05.041_bib7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0022-5347(17)56980-3","article-title":"Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study","volume":"121","author":"Kohnen","year":"1979","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.05.041_bib8","first-page":"1","article-title":"Prostatic inflammation in benign prostatic hyperplasia\u2014the third component?","volume":"1","author":"Nickel","year":"1994","journal-title":"Can J Urol"},{"key":"10.1016\/j.juro.2007.05.041_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1464-410X.1971.tb12050.x","article-title":"Chronic prostatitis in benign prostatic hyperplasia","volume":"43","author":"Odunjo","year":"1971","journal-title":"Br J Urol"},{"key":"10.1016\/j.juro.2007.05.041_bib10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0022-5347(18)35422-3","article-title":"The impact of acute and chronic inflammation in baseline biopsy on the risk of clinical progression of BPH: results from the MTOPS study","volume":"173","author":"Roehrborn","year":"2005","journal-title":"J Urol, suppl"},{"key":"10.1016\/j.juro.2007.05.041_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/00365590500497960","article-title":"Relation between acute urinary retention, chronic prostatic inflammation and accompanying elevated prostate-specific antigen","volume":"40","author":"Kefi","year":"2006","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.juro.2007.05.041_bib12","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.urology.2004.08.060","article-title":"Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study","volume":"64","author":"Simardi","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.juro.2007.05.041_bib13","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0090-4295(00)00519-7","article-title":"Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer","volume":"55","author":"Okada","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.juro.2007.05.041_bib14","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.ju.0000082252.49374.e9","article-title":"Leukocytes and bacteria in men with chronic prostatitis\/chronic pelvic pain syndrome compared to asymptomatic controls","volume":"170","author":"Nickel","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.05.041_bib15","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-5347(05)64572-7","article-title":"Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study","volume":"168","author":"Schaeffer","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.05.041_bib16","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1464-410X.2004.05148.x","article-title":"The three As of chronic prostatitis therapy: antibiotics, alpha-blockers and anti-inflammatories","volume":"94","author":"Nickel","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2007.05.041_bib17","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0090-4295(98)00540-8","article-title":"Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study","volume":"53","author":"Leskinen","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.juro.2007.05.041_bib18","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1464-410X.2003.04766.x","article-title":"A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis)","volume":"93","author":"Nickel","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2007.05.041_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534707012463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534707012463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2007.05.041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:51:28Z","timestamp":1784908288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1016\/j.juro.2007.05.041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1016\/j.juro.2007.05.041"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2007.05.041","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}